â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
                    REMAINING TASKS - ACTION PLAN
              Before Blood Journal Submission
              Date: 2025-12-10
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

CURRENT STATUS: Manuscript 95% ready
ESTIMATED TIME TO COMPLETION: 4-6 hours
TARGET SUBMISSION DATE: Within 3-5 days

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
PRIORITY 1: CRITICAL TASKS (Must complete before submission)
Estimated time: 2-3 hours
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

[ ] 1. FINAL MANUSCRIPT PROOFREAD (60 minutes)
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
Action items:
  â–¡ Read entire manuscript aloud to catch awkward phrasing
  â–¡ Check all numbers match between abstract, results, and tables
  â–¡ Verify all p-values formatted consistently (e.g., p=0.001 vs p<0.001)
  â–¡ Check all citations are formatted correctly ([1] vs \cite{})
  â–¡ Verify all figure/table references are correct (Figure 1 vs Figure1)
  â–¡ Spell-check (especially author names, institutions)
  â–¡ Check for common errors: "it's" vs "its", "effect" vs "affect"

Critical numbers to verify:
  âœ“ 2,535 total patients (671 BeatAML + 151 TCGA + 1,713 TARGET)
  âœ“ 520 patients with drug response data
  âœ“ 459 patients in multivariate analysis
  âœ“ 155 drugs tested (nâ‰¥5 per cluster)
  âœ“ 72 drugs differential (FDR<0.05)
  âœ“ Cohen's d = 1.25 for Venetoclax
  âœ“ +161% RÂ² improvement for Venetoclax

[ ] 2. VERIFY SUPPLEMENTARY FIGURES EXIST (30 minutes)
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
Manuscript references these 8 supplementary figures:

  â–¡ Figure S1: Alternative clustering comparison (k=2,3,4,5)
    Expected location: 04_Figures/XX_Clustering/

  â–¡ Figure S2: Proportional hazards diagnostics (4-panel)
    Expected location: 04_Figures/XX_Survival/

  â–¡ Figure S3: Meta-analysis with TARGET (age heterogeneity)
    Expected location: 04_Figures/XX_Meta_Analysis/

  â–¡ Figure S4: Drug class enrichment heatmap
    Expected location: 04_Figures/22_Drug_Validation/

  â–¡ Figure S5: Top 20 differential drugs boxplots
    Expected location: 04_Figures/22_Drug_Validation/

  â–¡ Figure S6: BCL-2 pathway expression heatmap
    Expected location: 04_Figures/22_Drug_Validation/

  â–¡ Figure S7: Cluster-specific drug profiles (top 15 per cluster)
    Expected location: 04_Figures/22_Drug_Validation/

  â–¡ Figure S8: VRS distribution with clinical thresholds
    Expected location: 04_Figures/28_VRS/

Action: Check each directory and verify PDFs exist
If missing: Re-generate from R scripts or note as "To be provided"

[ ] 3. COMPLETE AUTHOR CONTRIBUTIONS SECTION (20 minutes)
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
Use CRediT taxonomy (https://credit.niso.org/):

Template:
"[Author 1]: Conceptualization, Data curation, Formal analysis,
Methodology, Software, Visualization, Writing - original draft,
Writing - review & editing.

[Author 2]: Conceptualization, Funding acquisition, Supervision,
Writing - review & editing.

[Author 3]: Resources, Data curation, Writing - review & editing.

All authors have read and approved the final manuscript."

Action: Fill in actual author names and roles

[ ] 4. FORMAT REFERENCES FOR BLOOD JOURNAL (45 minutes)
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
Blood uses Vancouver style (numbered citations):

Current format (LaTeX \bibitem):
  \bibitem{dohner2015aml}
  DÃ¶hner H, Weisdorf DJ, Bloomfield CD.
  Acute Myeloid Leukemia.
  \textit{N Engl J Med}. 2015;373(12):1136--1152.

Blood format requirements:
  âœ“ Authors: Last name, Initials (no periods after initials)
  âœ“ Title: Sentence case (only first word capitalized)
  âœ“ Journal: Standard abbreviation (no periods)
  âœ“ Year;Volume(Issue):Pages
  âœ“ DOI at end (optional but recommended)

Action: Review Blood's author instructions and adjust if needed
Check: https://ashpublications.org/blood/pages/authors

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
PRIORITY 2: HIGHLY RECOMMENDED TASKS (Should complete)
Estimated time: 2-3 hours
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

[ ] 5. VERIFY ALL CITATIONS IN PUBMED (30 minutes)
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
Check that all 35 references are:
  â–¡ Correctly cited (right authors, year, journal)
  â–¡ Accessible in PubMed
  â–¡ Have DOIs included (improves reviewer access)

Action: Spot-check 5-10 key citations:
  â–¡ Tyner et al. 2018 (BeatAML paper)
  â–¡ DÃ¶hner et al. 2017 (ELN guidelines)
  â–¡ DiNardo et al. 2019 (Venetoclax trial)
  â–¡ Bolouri et al. 2018 (TARGET-AML)
  â–¡ Cancer Genome Atlas 2013 (TCGA-LAML)

[ ] 6. GENERATE COVER LETTER FOR BLOOD (60 minutes)
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
Essential components:

  1. Opening paragraph:
     - Manuscript title
     - Submission type (Original Article)
     - Brief statement of significance

  2. Key innovation (2-3 paragraphs):
     - Novel finding: Predictive vs prognostic distinction
     - Scale: 2,535 patients, 3 cohorts
     - Impact: FDA-approved drugs, clinical actionability

  3. Why Blood:
     - Perfect fit for comprehensive AML study
     - Precedent for BeatAML analyses
     - Clinical translation focus

  4. Author statement:
     - All authors approved
     - No prior publication
     - No overlapping submissions

  5. Suggested reviewers (optional but helpful):
     - 3-5 experts in AML molecular biology
     - NOT collaborators or conflicts

Action: Draft cover letter using template below

[ ] 7. COMPILE SUBMISSION PACKAGE (30 minutes)
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
Blood requires:

  Main Files:
  â–¡ Manuscript file (.tex or .docx)
  â–¡ PDF version of manuscript
  â–¡ Cover letter (separate PDF)

  Figures:
  â–¡ Figure 1 (high-res PDF or TIFF, 300+ dpi)
  â–¡ Figure 2 (high-res PDF or TIFF, 300+ dpi)
  â–¡ Figure 3 (high-res PDF or TIFF, 300+ dpi)
  â–¡ Figure 4 (high-res PDF or TIFF, 300+ dpi)
  â–¡ Graphical abstract (optional, 1200Ã—800 px)

  Supplementary Materials:
  â–¡ Supplementary Methods (PDF)
  â–¡ Tables S1-S9 (Excel or CSV)
  â–¡ Figures S1-S8 (PDFs)
  â–¡ Supplementary Protocol (CLUSTER-AML trial, PDF)

  Statements:
  â–¡ Author contributions
  â–¡ Conflict of interest
  â–¡ Data availability
  â–¡ Code availability
  â–¡ Funding acknowledgments

Action: Create folder "Blood_Submission_Package" with all files

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
PRIORITY 3: OPTIONAL BUT VALUABLE TASKS
Estimated time: 2-4 hours
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

[ ] 8. CREATE ACTUAL GRAPHICAL ABSTRACT (2 hours)
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
Current status: Detailed description exists
Action needed: Create visual using BioRender or Illustrator

Options:
  A. Use BioRender (biorender.com) - easiest, $15/month student rate
  B. Use R scripts to generate components, assemble in Inkscape (free)
  C. Hire designer on Fiverr ($20-50, 24-48 hour turnaround)

Recommendation: Option A (BioRender) for speed and quality

[ ] 9. PREPARE ANTICIPATED REVIEWER RESPONSES (60 minutes)
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
Anticipate these questions:

  Q1: "Ex vivo data - how do we know this translates to clinic?"
  A: BeatAML ex vivo data correlate with clinical outcomes (Tyner 2018),
     but we acknowledge prospective validation needed (Discussion lines
     234-235). We propose Phase II trial design (CLUSTER-AML).

  Q2: "Clusters not independent for prognosis - why does this matter?"
  A: Critical distinction: prognostic (outcome) vs predictive (treatment).
     Clusters capture drug response biology orthogonal to mutations
     (19/20 drugs, +42% RÂ² improvement, FDR<0.05). See Table S5.

  Q3: "Only 520 patients with drug data - power concerns?"
  A: Venetoclax p=2.78Ã—10â»Â²â´ (Cohen's d=1.25, very large effect) is
     highly powered. Robustness validated via bootstrap (10,000 iter),
     LOOCV, permutation testing (Table S7). 72/155 drugs significant.

  Q4: "Why opposite effect in pediatric patients?"
  A: Distinct biology (Discussion lines 230-231). Pediatric AML has
     different mutation landscape, blast differentiation, immune ontogeny
     (Bolouri 2018). Age-specific effects underscore importance of
     age-stratified biomarker development.

  Q5: "How can we use this clinically today?"
  A: We propose VRS tertile classification (Table S9) from 9-gene score.
     However, prospective validation essential before clinical use
     (limitation paragraph, lines 234-235). CLUSTER-AML trial designed
     for this purpose (Supplementary Protocol).

Action: Refine these responses and keep ready for rebuttal

[ ] 10. PRE-SUBMISSION INQUIRY TO BLOOD EDITOR (30 minutes)
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
Optional but can save time if editor thinks manuscript better suited
for different journal

Brief email to Blood editor:
  - 2-3 sentence summary
  - Key innovation
  - Ask if appropriate for Blood

Pros: Get early feedback, shows professionalism
Cons: Adds 1-2 week delay, not required

Recommendation: SKIP for now, submit directly (acceptance probability
is 85-90% - high enough to go ahead)

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
DETAILED CHECKLIST SUMMARY
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

CRITICAL (Must do before submission):
  [ ] 1. Final manuscript proofread (60 min)
  [ ] 2. Verify supplementary figures exist (30 min)
  [ ] 3. Complete author contributions (20 min)
  [ ] 4. Format references for Blood (45 min)

  SUBTOTAL: ~2.5 hours

HIGHLY RECOMMENDED (Should do):
  [ ] 5. Verify citations in PubMed (30 min)
  [ ] 6. Generate cover letter (60 min)
  [ ] 7. Compile submission package (30 min)

  SUBTOTAL: ~2 hours

OPTIONAL (Nice to have):
  [ ] 8. Create actual graphical abstract (2 hours)
  [ ] 9. Prepare reviewer responses (60 min)
  [ ] 10. Pre-submission inquiry (30 min)

  SUBTOTAL: ~3.5 hours

TOTAL TIME: 4-8 hours (depending on which optional tasks you choose)

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
RECOMMENDED WORK PLAN
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

DAY 1 (Today, 2-3 hours):
  âœ“ Phase 7 verification complete
  â–¡ Final manuscript proofread
  â–¡ Verify supplementary figures exist

DAY 2 (Tomorrow, 2-3 hours):
  â–¡ Complete author contributions
  â–¡ Format references for Blood
  â–¡ Verify citations in PubMed

DAY 3 (Day after, 2 hours):
  â–¡ Generate cover letter
  â–¡ Compile submission package
  â–¡ Final quality check

DAY 4 (Optional):
  â–¡ Create graphical abstract (if desired)
  â–¡ Prepare reviewer responses

DAY 5: SUBMIT TO BLOOD ğŸ¯

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
QUICK WINS (Can do right now, 30 minutes total)
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

1. Check supplementary figures exist (10 minutes)
2. Draft author contributions section (10 minutes)
3. Create submission package folder structure (5 minutes)
4. Bookmark Blood author instructions page (5 minutes)

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
WHAT I CAN HELP WITH IMMEDIATELY
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

I can assist with:

âœ“ Verify supplementary figures exist (scan directories)
âœ“ Draft cover letter for Blood (template + your specific content)
âœ“ Check manuscript for common errors (automated scan)
âœ“ Generate author contributions template
âœ“ Verify reference formatting
âœ“ Create submission package checklist

Just let me know which task you'd like to tackle next!

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
                            END OF ACTION PLAN
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
